The Doctor's Dose

Novo Nordisk Wegovy MASH approval: Why NVO is jumping—and how day traders can trade it Quick take Novo Nordisk shares pop after the FDA grants accelerated approval for Wegovy to treat MASH (metabolic dysfunction-associated steatohepatitis) with liver fibrosis in...

DeepSeek’s AI Model Delay and the Impact on Intraday Trading Opportunities China’s AI Ambitions Face Technical Headwinds The delay in the DeepSeek AI model underscores a significant challenge in Beijing’s push to reduce reliance on U.S. technology. The Chinese AI...

Weight-Loss Drug Stocks and Day Trading Opportunities Pharma’s Former Darling Turns Volatile The meteoric rise of weight-loss drug stocks such as Novo Nordisk and Eli Lilly was once seen as a safe haven in the pharmaceutical sector. Fueled by the popularity of GLP-1...

Zelensky–Trump Meeting Market Impact: What Traders Should Expect As President Volodymyr Zelensky returns to Washington with a cohort of European leaders, the Zelensky–Trump meeting market impact will hinge on three things: the shape of potential security guarantees,...

Big Tech AI Talent War: How Reverse Acquihires Could Reshape Silicon Valley The Big Tech AI talent war is pushing Microsoft, Meta, Google and others to pursue a new playbook—poach founders and core researchers, license the IP, and leave the startup shell behind. It’s...

Disney and Marvel Leaving Georgia: Intraday Stock Action & What It Means for Cleveland What Happened (and Why It Matters) Reports indicate Disney’s Marvel is shifting most big-budget productions away from Georgia and toward the United Kingdom, citing a better...

Trump’s Emerging Market Behavior: Is the US Beginning to Look Like Argentina? For decades, the United States has been the world’s benchmark for financial stability, transparency, and institutional independence. Yet in President Donald Trump’s second term, analysts and...

Housing Market Correction Indicators: 3 Key Trends to Watch Despite appearing stagnant on the surface, the U.S. housing market is showing early signs of a potential shift—and possibly a correction. Economists are closely monitoring several key indicators to assess...

Uber’s Autonomous Ambitions Spark Tesla Volatility: What Traders Need to Watch Shares of Uber Technologies (UBER) climbed in early trading Wednesday after the company posted strong second-quarter earnings, beat across key metrics, and unveiled a $20 billion share...

Pfizer Raises Guidance Amid Drug Pricing Pressure: What Traders Should Know  Pfizer (PFE) raised its full-year earnings guidance this week, signaling early success in its multibillion-dollar cost-cutting strategy while navigating political pressure from President...

Teradyne Leads the S&P 500 After Strong Earnings and AI Momentum Teradyne (TER) shares surged Wednesday, topping the S&P 500 leaderboard after the company delivered solid second-quarter results and projected accelerating growth tied to artificial intelligence...

Super Micro (SMCI) Slashes Guidance—And Still Misses the Mark for Wall Street Shares of Super Micro Computer Inc. (SMCI) plunged over 17% in premarket trading Wednesday after the company lowered its full-year revenue forecast and offered little reassurance on margins,...

Ford tariff impact 2025 Ford Motor Co. is feeling the sting of rising trade tensions. On Wednesday, the automaker warned investors that tariff-related costs are now expected to total $2 billion in 2025—a $500 million increase from its previous estimate in May. While...

Trade Truce or Powder Keg? Trump’s EU Deal Leaves Markets Guessing In a week already brimming with geopolitical uncertainty, a fragile U.S.–EU trade agreement has injected fresh volatility into global markets. European Union officials announced that they would suspend...

Intel CEO Lip-Bu Tan Faces Internal Rift, Political Pressure, and Strategic Crossroads Intel’s new CEO, Lip-Bu Tan, has been in the job for just a few months, but already finds himself at the center of a high-stakes battle — one that spans boardroom disputes,...